Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/23 18:30 | 9/12/23 | OLMA | Health | Drug | Pharmaceutical Preparations | Graham G. Walmsley | CA | D | 1 | P.m | 6,871 | 10.74 | 0 | 640 | 17 | 4,384 | I | |||||||||||||||
12/8/23 16:19 | 12/6/23 | OLMA | Health | Drug | Pharmaceutical Preparations | Paradigm Biocapital Advisors LP | NY | T | 1 | P | 1,160 | 11.60 | 0 | 100 | 1 | 7,904 | I | |||||||||||||||
9/14/23 16:25 | 9/12/23 | OLMA | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | DT | 1 | P.d | 14,818 | 9.84 | 0 | 1,506 | 624 | M | ||||||||||||||||
4/7/23 16:30 | 4/6/23 | OLMA | Health | Drug | Pharmaceutical Preparations | Kovacs Shane William Charles | CA | O | CH. OPER | 1 | P | 0 | 0.00 | 0 | 10 | 3 | 396 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |